drugset / Trial / NCT02173184

Safety and Efficacy Study of Gynevac Lactobacillus Vaccine in the Treatment of Bacterial Vaginosis

NCT02173184 ↗

Phase 3 Unknown 240 enrolled Amvac Kft.
RandomizedParallel-groupTriple-blindTreatment

Summary

To investigate the efficacy (therapeutic response) of Gynevac vaccination following a 5-shot treatment period in patients with bacterial vaginosis, based on the Nugent Score and the Amsel criteria

Timeline

Start
2014-06
Primary completion
2015-04
Completion
2015-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Gynevac Vaccine — Intramuscular

Indications